Form 8-K - Current report:
SEC Accession No. 0001140361-24-010584
Filing Date
2024-03-01
Accepted
2024-03-01 06:01:58
Documents
14
Period of Report
2024-03-01
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K ef20022937_8k.htm   iXBRL 8-K 193624
  Complete submission text file 0001140361-24-010584.txt   343591

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA krtx-20240301.xsd EX-101.SCH 3865
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE krtx-20240301_lab.xml EX-101.LAB 21966
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krtx-20240301_pre.xml EX-101.PRE 16044
15 EXTRACTED XBRL INSTANCE DOCUMENT ef20022937_8k_htm.xml XML 4214
Mailing Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

EIN.: 270605902 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38958 | Film No.: 24706710
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)